BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Melanoma Institute Australia - ECPv6.16.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://melanoma.org.au
X-WR-CALDESC:Events for Melanoma Institute Australia
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20270403T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20271002T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20280401T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20280930T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20261111T170000
DTEND;TZID=Australia/Sydney:20261111T170000
DTSTAMP:20260331T013110Z
CREATED:20260331T013110Z
LAST-MODIFIED:20260331T013110Z
UID:10000276-1794416400-1794416400@melanoma.org.au
SUMMARY:NHMRC Partnership Projects
DESCRIPTION:The Partnership Project funding scheme provides funding and support to create new opportunities for researchers and policy makers to work together to define research questions\, undertake research\, interpret the findings and implement the findings into policy and practice. \n\nPartnership Projects create partnerships among decision makers\, policy makers\, managers\, clinicians and researchers and answer a specific research question to influence health and wellbeing through changes in the delivery\, organisation\, funding and access to health services. \nPartnership Projects will support collaborations\, within the Australian context\, that translate research evidence into health policy and health practice\, to improve health services and processes. \nThe objectives of the Partnership Project scheme are to: \n• Meet the need for more effective integration of research evidence into health policy and service delivery\n• Create partnerships among policy makers\, managers\, service providers and researchers\n• Provide support to answer often complex and difficult questions that policy makers\, managers and service providers face when making decisions and implementing policies that affect Australians’ health and health care\n• Be highly responsive to the priorities of government\, the community and health professionals\n• Enable applicants to apply for funding at any time during the year to allow researchers and Partner Organisations to develop timely collaborations. \n\nKey Dates for Peer Review Cycle 2:\nApplications open: 19 March 2026\nNHMRC-approved Administering Institutions waiver due: 8 July 2026\nMinimum data due: 22 July 2026\nApplications close: 5 August 2026\nPeer review meetings: 17-19 November 2026 \nKey Dates for Peer Review Cycle 3:\nApplications open: 23 July 2026\nNHMRC-approved Administering Institutions waiver due: 14 October 2026\nMinimum data due: 28 October 2026\nApplications close: 11 November 2026\nPeer review meetings: 2-4 March 2027 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/nhmrc-partnership-projects/
CATEGORIES:Grants,Industry
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/03/NHMRC-Partnership-600-x-338-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20270331T170000
DTEND;TZID=Australia/Sydney:20270331T170000
DTSTAMP:20260618T051009Z
CREATED:20260618T051009Z
LAST-MODIFIED:20260618T051009Z
UID:10000310-1806512400-1806512400@melanoma.org.au
SUMMARY:MRFF 2022 Frontier Health and Medical Research Grant
DESCRIPTION:This grant program will support researchers to pursue big ideas to develop new products and interventions and implement these into clinical practice\, benefiting patients\, clinicians\, and the health system. \nThis grant opportunity offers funding to support medical research and medical innovation programs of research (up to $25 million per program) that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition\, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re‑purpose existing health technologies in a novel way. \nThe initial application process to secure funding through this grant opportunity will be conducted in two stages: \n\nexpression of interest (EOI) – outlining a proposed program of research comprising of a series of linked projects with a 10-year time horizon\nfull application\, (invitation only – following EOI) for a project of up to 5 years under the program of research.\n\nApplicants may propose to commence research at any stage in the research pipeline from proof-of-concept\, with the intention of achieving full implementation of the proposed technology in 10 years. \nFunding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only. \n\nKey Dates:\nExpressions of Interest close: 31 March 2027\nLast grants awarded by: 30 June 2028 \nSEE GRANT GUIDELINESSEE WEBSITE
URL:https://melanoma.org.au/event/mrff-2022-frontier-grant/
CATEGORIES:Grants,Discovery
ATTACH;FMTTYPE=image/jpeg:https://melanoma.org.au/wp-content/uploads/2026/06/MRFF-2022-Frontier-Health-and-Medical-Research-Grant-600-x-338-px.jpg
END:VEVENT
END:VCALENDAR